Clinical Trial Update: Single Dose Escalation First Time in Human PK Study [Phase 1]

View source ↗

Summary

GlaxoSmithKline reports completion of a first-in-human, single-dose escalation PK study in Phase 1.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Bacterial | Phase 1 | Status: COMPLETED